Interesting observation and which I similarly highlighted in my thread as well except that a more appropriate comparison ought to be 4DS also in chip category and has no revenues but a very big promise waiting to be validated . The difference is that 4DS trades at $77m market cap not $660m . I have no interest in both stocks . But yes BRN is trading at substantial premium to its progress to date and no business traction despite years in operation. BRN suffered a waterfall chart until March this year because it never delivered the promise when it was touted as a tech potential during tech stock boom of the 2017, so now in COVID ISO speculative frenzy , it's AI positioning came at the right time with another tech boom. The question is , is this time for real or another hype 2.0 in similar veins 3 years ago ? Incidentally Alex Waislitz owns both BRN and YOJ and both have been carrying big promises story with negligible almost zero revenues but a bloated share base.
- Forums
- ASX - By Stock
- BRN
- 30 cents, $0.3 next week
30 cents, $0.3 next week, page-191
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $366.5M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.8¢ | $740.8K | 3.668M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
84 | 1406020 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 494042 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
83 | 1405906 | 0.195 |
59 | 1580534 | 0.190 |
31 | 1283131 | 0.185 |
52 | 1541743 | 0.180 |
17 | 632162 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 494546 | 16 |
0.205 | 916978 | 19 |
0.210 | 1596365 | 29 |
0.215 | 534039 | 23 |
0.220 | 758461 | 24 |
Last trade - 14.05pm 15/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online